Chronobiology and mood disorders by Wirz-Justice, Anna
n order for Dialogues in Clinical Neuroscience to
be truly designated “dialogues,”I will raise specific and
critical questions about the putative circadian rhythm dis-
turbances in depression,provide a model within which to
understand them,and summarize the present status and
application of chronobiological therapies. This short
overview will not go into detail of the clinical and exper-
imental findings related to biological rhythms in depres-
sion,which have been extensively reviewed elsewhere.
1-9
Chronobiologists predicate their work on a primary axiom,
that temporal order is essential for health.Psychological,
behavioral, physiological, and hormonal rhythms are
specifically and functionally timed (entrained or syn-
chronized) with respect to sleep and the day-night cycle.
The converse premise implies that temporal disorder
must have clinical correlates.Rhythmic characteristics of
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The clinical observations of diurnal variation of mood and early morning awakening in depression have been incorpo-
rated into established diagnostic systems, as has the seasonal modifier defining winter depression (seasonal affective dis-
order, SAD). Many circadian rhythms measured in depressive patients are abnormal: earlier in timing, diminished in ampli-
tude, or of greater variability. Whether these disturbances are of etiological significance for the role of circadian rhythms
in mood disorders, or a consequence of altered behavior can only be dissected out with stringent protocols (eg, constant
routine or forced desynchrony). These protocols quantify contributions of the circadian pacemaker and a homeostatic
sleep process impacting on mood, energy, appetite, and sleep. Future studies will elucidate any allelic mutations in 
“circadian clock”–related or “sleep”-related genes in depression. With respect to treatment, antidepressants and mood
stabilizers have no consistent effect on circadian rhythmicity. The most rapid antidepressant modality known so far is
nonpharmacological: total or partial sleep deprivation in the second half of the night. The disadvantage of sleep depri-
vation, that most patients relapse after recovery sleep, can be prevented by coadministration of lithium, pindolol, sero-
tonin (5-HT) reuptake inhibitors, bright light, or a subsequent phase-advance procedure. Phase advance of the sleep-
wake cycle alone also has rapid effects on depressed mood, which lasts longer than sleep deprivation. Light is the
treatment of choice for SAD and may prove to be useful for nonseasonal depression, alone or as an adjunct to medica-
tion. Chronobiological concepts emphasize the important role of zeitgebers to stabilize phase, light being the most impor-
tant, but dark (and rest) periods, regularity of social schedules and meal times, and use of melatonin or its analogues
should also be considered. Advances in chronobiology continue to contribute novel treatments for affective disorders. 
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ancient times.However,it is still unclear whether circa-
dian rhythms are reliably linked with psychopathology,if
they provide clues to underlying mechanisms,and how
they can be understood with respect to the established
neurotransmitter models of depression.
The first question is common to all clinical research:what
do we mean by biologically homogeneous groups? Here
too,diagnostic issues are the crux.In addition to the dis-
tinction unipolar,bipolar,or seasonal affective disorder
(SAD), the stage of the illness may be important for
chronobiological disturbances.Acute depression is prob-
ably different from chronic, and in rapid cyclers it is
known that there is a continuous shift in circadian phase
during depression and that this reverses during mania.
1
Given that antidepressants act on neurotransmitter
mechanisms also involved in circadian rhythm genera-
tion and entrainment,only untreated patients may reveal
an “endogenous”rhythm disturbance,if present.
The second question regards conceptual clarity.What do
we mean by a clock disturbance in depression? What one
sees clinically may have its origins at a variety of different
levels—not necessarily the hypothalamic biological clock
itself, but epiphenomena related to altered rhythmic
behavior, disturbed sleep, or abnormal environmental
input.
The third question is whether the studies purporting to
document circadian rhythm disturbances in depression
have been adequately carried out.Alas,methodological
issues characterize most investigations—not in terms of
scientific caliber or intent,but because it was previously
not sufficiently recognized how strongly “masking”
(behavioral or environmental factors that modify the
variable measured) obscures the underlying endogenous
rhythms.This is a particular problem with measuring the
core body temperature rhythm,since temperature is eas-
ily and rapidly masked by motor activity,postural change,
meals,etc.Cortisol increases with stress,particularly at
the evening nadir;thus,this circadian marker is also often
masked by psychophysiological response.Melatonin,the
pineal hormone considered to provide the best estimate
of circadian rhythm phase,is suppressed by light,partic-
ularly in the evening:it is sensitive to masking by light as
low as ca 100 lux.
10 Thus, even indoor room light may
delay the apparent onset of nocturnal secretion.Only in
the last decade have controlled protocols using state-of-
the-art chronobiological techniques provided unequivo-
cal circadian markers.
The fourth question concerns which models are useful.
Concepts of an underlying genetic and stress-related vul-
nerability for depression can be discussed in terms of
both neurotransmitter and circadian rhythm dysregula-
tion.Here,I will draw on the two-process model of sleep-
wake regulation
11 as a way of understanding some aspects
of depressive symptomatology.
The final question is whether we can find out about puta-
tive circadian mechanisms underlying affective disorder
through understanding clinically successful chronobiolog-
ical treatments.Circadian rhythm or sleep manipulations
do improve depression and provide some fascinating clues.
Clinical observations
Periodicity in affective disorders (from seasonal recur-
rence to 48-h rapid cycling) is the clinical observation;
diurnal variation of mood,early morning awakening,and
sleep disturbances are the classical symptoms that have
linked depression with circadian rhythm function.Many
rhythms, such as core body temperature, cortisol,
monoamine metabolism, are different in depressive
patients:phase advanced (timed earlier) with respect to
the sleep-wake cycle, diminished in amplitude, and/or
with day-to-day variability in their synchronization to
social cues (entrainment).
1 However,altered rhythmicity
could be either a cause or an effect of altered affective
state.Both could independently reflect abnormalities in
a third system,such as psychomotor activity.Apparent
lability may be caused solely by lack of appropriate feed-
back to the circadian system (eg, reduced activity). In
addition,sleep disturbances are inextricably linked with
depressive illness.These clinical observations can be for-
malized in terms of circadian and sleep physiology.
The neurobiology of circadian rhythms
Circadian rhythms are generated by a master pacemaker
located in the suprachiasmatic nuclei (SCN) of the ante-
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Selected abbreviations and acronyms
HPA hypothalamo-pituitary-adrenal (axis)
5-HT serotonin (5-hydroxytryptamine)
PVN paraventricular nucleus
rTMS repetitive transcranial magnetic stimulation
SAD seasonal affective disorder
SCN suprachiasmatic nucleus
SSRI selective serotonin reuptake inhibitorrior hypothalamus.
12 Individual, genetically determined
endogenous periodicity is slightly different from 24 h (usu-
ally longer) and requires daily synchronization to the 
24-h day by “zeitgebers,” which are regularly recurring
environmental signals.Light is the major zeitgeber for the
SCN,transmitted by novel photoreceptors in retinal gan-
glion cells.
13This nonvisual,non–image-forming pathway
via the retinohypothalamic tract counts photons,in par-
ticular the transitions at dawn and dusk, and is actively
gated by a second clock in the eye.
14 An indirect visual
pathway reaches the SCN via the intergeniculate leaflet of
the lateral geniculate complex.From the raphe nucleus,a
serotonergic pathway provides nonphotic input to the
SCN,and it is perhaps of some importance in the context
of depression that concentrations of serotonin (5-HT) in
the brain are highest in these nuclei.An important output
leads from the SCN to the paraventricular nucleus (PVN)
and via a multisynaptic pathway to the pineal gland,where
melatonin is synthesized at night and suppressed by light
during the day.Melatonin transduces the night signal for
the body as the nocturnal duration of hormone secretion
(“the day within”).
15 Melatonin onset in the early evening
has proved to be the most reliable biological marker of cir-
cadian timing (provided samples are taken under dim light
conditions).
16 The PVN is also the site of corticotropin-
releasing factor synthesis,ie,part of the hypothalamo-pitu-
itary-adrenal (HPA) axis.The nadir of the cortisol rhythm
provides a reliable output of the SCN clock (whereas the
maximum is influenced by environmental factors).
17
Zeitgeber stimuli,of which light is the most important,
can phase shift—and thus entrain—the SCN.
18,19 Light
during the early part of the night induces phase delays,
whereas light given in the second half of the night (after
the core body temperature minimum) induces phase
advances.
18,19 Administration of exogenous melatonin
shows patterns nearly opposite to phase shifting to light.
20
Other nonphotic zeitgebers (exercise,perhaps sleep or
darkness,and nutrients) have been less well investigated
and are probably weaker zeitgebers than light.
21 Social
zeitgebers (jobs,social demands or tasks,and personal
relationships) may act directly or indirectly on the SCN,
since they determine the timing of meals,sleep,physical
exercise,and outdoor light exposure.These social factors
also have the potential to disrupt circadian rhythms.
22
Some of the particular psychosocial precipitants of
depressive disorder,such as life events,chronic stresses,
or lack of appropriate social support systems,may act as
precipitants by disrupting circadian rhythms.
Clocks everywhere
The concept of a master pacemaker driving all circadian
rhythms has been very useful. It needs to be supple-
mented by the concept of peripheral clocks distributed
in every organ and perhaps in every cell.
23 Each organ
has its own relevant and specifically timed circadian
rhythms—of heart rate, liver metabolism, and kidney
transport, and also of gene expression. Under normal
conditions, all rhythms are synchronized by the SCN.
23
The SCN signal is translated mainly by the PVN into a
hormonal and autonomic signal to peripheral organs.
Visceral,sensory,and hormonal information feeds back
on the hypothalamus,providing fine-tuning to synchro-
nize time-of-day input from the external light-dark cycle
with metabolic information from the inside.The phase of
each rhythm can be adjusted by differential responses of
a given tissue’s circadian clock to a signal from the SCN
or from the environment.Such a system can adjust well
to small,gradual changes in the input signal (such as sea-
sonal changes in daylength),but may become temporar-
ily and severely disorganized if the change in phase of
this signal is abrupt and large (as is most obvious for
rapid transmeridian travel and shift work).How could
this system go wrong in affective disorders? 
Consider the vegetative symptoms that are an integral
part of the depressive syndrome, and often appear as
forerunners. If sleep is no longer in correct alignment
with the inner or outer clock,if food intake decreases,or
if behavior turns inward so that motor activity declines
and the amount of outdoor light exposure is reduced (as
well as social contact), is it not conceivable that these
behaviors each act on different clocks,shifting their tim-
ing with respect to each other and the day-night cycle to
different degrees? This temporal cacophony could initi-
ate an internal stress reaction. Given the concept of a
final common neuroendocrine pathway of depression via
hyperactivity of the HPA axis,this may be an important
mediating system from physiology to psyche.
Clock genes, sleep genes
Individual preference in timing of the sleep-wake cycle
(chronotype, ie, whether “larks” or “owls”)
24 is deter-
mined by clock genes,of which 10 have been cloned so
far.
25 Individual sleep and wake duration (long sleepers
versus short sleepers) is also probably programmed in
certain sleep genes
26).Since the timing of sleep appears
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may be relevant to a chronobiological vulnerability for
depression,in that wrong or poor alignment of internal
phase with the outdoor world increases susceptibility to
depressive mood swings.Although familial forms of cir-
cadian sleep disorders (such as advanced or delayed
sleep phase syndrome) have been found, with allelic
mutations on one or other of the clock genes,
27-29 the first
studies in depression have been negative (eg,the clock
gene in major depression
30 or the per2 gene in bipolar dis-
order
31).Circadian clock-related polymorphisms seem to
be related,interestingly enough,to susceptibility to SAD
together with evening chronotype.
32This research is still
in its infancy.
Circadian rhythm desynchronization
It is unlikely, however, that affective disorders will be
characterized as simple clock gene mutations. Rather,
internal desynchronization may be a major contributing
factor to mood state.New findings on desynchronization
in clock gene expression illustrate this vividly.The clock
genes in the SCN gradually adapt to a phase shift of the
light-dark cycle (as found in shift work and transmerid-
ian travel),whereas clock genes in muscle,liver,and lung
resynchronize at their own rates.
33This results in a dou-
ble desynchronization,not only between internal (SCN)
and external time,but also between different clocks and
organs within the body itself.The temporal orchestra can
quickly get out of tune. Moreover, the different organ
clocks respond to different,specific zeitgebers;for exam-
ple,food can shift the clock in the liver rather fast,but
light does not affect it;the SCN clock reacts to light,but
is not influenced by meals.
34 Peripheral clocks in muscle
may be synchronized by exercise.
This provides a new view on circadian rhythm distur-
bances in depression. Since peripheral clocks comple-
ment the central clock’s function of maintaining tempo-
ral order,more clocks in body and brain only add to the
possibilities of this organization going awry.There may
be different patterns of desynchronization that result in
similar physiological or psychological consequences.The
classical idea of internal circadian phase disturbances in
depression can be extended to zeitgeber phase distur-
bances.
6 Even an apparently minor reduction in zeitge-
ber strength or diminished behavior can loosen tempo-
ral coordination,not only between internal rhythms,but
also with respect to the social and physical clock,result-
ing in mood detriments,diurnal variation,and day-to-day
mood variability.However,the precise neurobiological
mechanisms by which altered circadian phase relation-
ships lead to altered mood state remain unknown.
Bipolar disorder,in particular rapid cycling,is the most
striking example of a mood disorder linked to abnormal
or changing circadian rhythm phase.
1 Here the environ-
ment (light or dark) as well as behavior (sleep or its
deficit)
35 strongly modulate affective state and,recently,
these factors have begun to be used as treatments.
36-39
Sleep regulation
The sleep-wake cycle is the most obvious circadian
rhythm in humans,and sleep disturbances are a promi-
nent feature of depression.In the two-process model of
sleep regulation,a homeostatic process S increases dur-
ing waking and declines exponentially during sleep; it
interacts with a circadian process C to determine the tim-
ing and architecture of sleep.
11 This model can also be
used to describe possible disturbances in either process
during depression (Figure 1A).The clinical sleep distur-
bance with early morning awakening could arise from an
impaired build-up of S during waking (diminished sleep
pressure) or an earlier timing of process C.There are a
number of sleep manipulations that improve clinical state
(see below and Table I).The rapid antidepressant effect
of one night’s sleep deprivation is proposed to act by a
short-term increase in process S to normal levels.
40The
slower antidepressant effect of a phase advance of the
sleep-wake cycle
8 may be related to more gradual shifts
towards a correct phase relationship with respect to
process C.Other possibile abnormalities could lie in the
decline of S during sleep,or circadian period,phase,or
amplitude (process C).
How to measure process C and S
The model helps clarify which biological markers could
be measured to test these hypotheses (Figure 1B).
Correct methodology is important to define experimen-
tal conditions where masking is reduced.There are two
major approaches, both requiring subjects to undergo
demanding and highly controlled protocols.The first pro-
tocol is the “constant routine,”in which subjects remain
awake during an entire 24-h cycle or longer,with exter-
nal and behavioral conditions constant (very low light
levels not to affect the circadian pacemaker,supine pos-
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318ture in bed,and regular small isocaloric meals).The con-
stant routine provides information about process C:
amplitude and phase estimates of rhythms in,for exam-
ple, melatonin, cortisol, and core body temperature.
18
Only such parameters that are little affected by sleep
deprivation are valid as circadian markers.The second
protocol is “forced desynchrony,”in which subjects live
on very long or very short sleep-wake cycles,while the
clock remains at its endogenous period,somewhat longer
than 24 h.This protocol allows quantification of many
measures with respect to either time of day (process C)
or to duration of prior wakefulness (process S).
18
Process C and S in SAD
Both the constant routine and forced desynchrony pro-
tocols have been employed in patients with SAD,both
when depressed and euthymic, in winter and summer.
The endogenous period appears normal.
41A phase delay
in process C (as measured by core body temperature or
melatonin rhythms in constant routine) has been found,
42
but not in all studies or all markers.
41,43 The decline in
process S (as measured by spectral analyses of the sleep
electroencephalogram [EEG]) was no different in SAD
patients compared with controls.
44,45 However,the rise in
process S (as measured by spectral analyses of the wake
EEG) was different,indicating a factor related to day-
time vigilance.
46,47Wake EEG patterns in evening chrono-
types are similar to this,
48 which may mean that the above
finding is not pathogenetic for SAD, since the patient
chronotype is skewed towards “owls,”shows the above
tendency to phase delay,and has common clock-related
polymorphisms.
32
War of the zeitgebers?
What is fascinating is that both circadian and wake-depen-
dent factors contribute to a subjective measure such as
mood.This has been demonstrated in healthy subjects in
both protocols.
6,41,49,50The day-to-day change in patterns of
diurnal mood variation in a forced desynchrony protocol
has remarkable similarities to the day-to-day variability in
diurnal mood variation found in depressive patients,and
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Figure 1. A. The two-process model of sleep regulation, considered in
terms of what could go wrong in depression. The homeosta-
tic component (process S) builds up during wakefulness and
declines during sleep. The circadian pacemaker (process C)
ticks along at its individual (genetically programmed) endoge-
nous period. Decreased amplitude would increase variability
of daily timing and it would be more vulnerable to phase
shifts. If the rhythm was advanced or delayed in phase, the
resultant altered phase relationships between process C and
sleep timing could explain many depressive phenomena. B.
Biological markers of process S and process C. The exponen-
tial rise in sleep pressure can be followed by theta-alpha (θ/α)
power in the wake electroencephalogram (EEG). The expo-
nential decline in sleep pressure is evident in slow-wave activ-
ity in the sleep EEG. In a constant routine protocol, the
rhythms of core body temperature (CBT), melatonin, and cor-
tisol provide estimates of circadian phase and amplitude. In
a forced desynchrony protocol, the endogenous period of the
circadian pacemaker can be reduced as well as the relative
contributions of process C and process S to any given mea-
sure, from psychological to physiological.
S decline
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Separate C and S (forced desynchrony)even more similarity to the mood patterns following a
phase advance of the sleep-wake cycle.
8Thus,mood fluc-
tuations can indeed be understood in terms of abnormal
or changing phase relationships.
Mood-related cognitive and attributional disturbances
have been postulated to be sequelae of shifting circadian
rhythms.
5This is an important point for the above findings.
If SAD patients are vulnerable to short winter days,is this
an abnormality of the biological clock,or is it rather a sub-
jective interpretation of internal temporal disorder? The
following findings are perhaps relevant to this argument.
Some subjects in experiments where they live free of
time cues manifest spontaneous internal desynchroniza-
tion,in that their sleep-wake cycle desynchronizes from
circadian rhythms such as core body temperature.They
do not notice that this phenomenon has occurred,nor do
they show any decrement in mood or performance—on
the contrary,they feel rather well.
51This is in marked con-
trast to the situation resulting from external desynchro-
nization, when sleep timing is shifted by shift work or
transmeridian travel.Here the internal desynchroniza-
tion between sleep and the clock is additionally in con-
flict with light and social zeitgebers in the outer world;
and it is postulated that this aspect may underlie the
often-associated depressive disturbances.
5,52
It may not only be phase relationships that are important,
but perhaps also the light-dark ratio (daylength or pho-
toperiod).Some of the evidence for SAD suggests that the
duration of nocturnal melatonin secretion is important for
triggering psychopathology in winter.
53 Conversely, in a
study of healthy subjects kept on long winter nights,one
volunteer became severely suicidal,even though all the
others felt remarkably well on this protocol.
54
Diurnal variation or instability of mood can thus be quite
well explained by considering changing phase relation-
ships between processes C and S.Even in healthy sub-
jects,some phase relationships are favorable,others unfa-
vorable. Modest but reliable mood decrements occur
after a phase delay of the sleep-wake cycle
55 (reviewed in
reference 5).Sudden delays (as induced by night shift or
westwards flights across time zones) can even precipitate
depressive symptoms in predisposed individuals with a
history of affective illness.
56,57This points to a particular
vulnerability of mood state when sleep is shifted later
with respect to circadian rhythms. Such an association
also appears to be valid for the circadian sleep disorder
of delayed sleep phase syndrome (inappropriately late
sleep timing with respect to the endogenous circadian
clock). In these persons there is a high comorbidity of
depressive symptoms.
58 Conversely, flying east may be
more correlated with hypomanic or manic states.
56,57
Psychopharmacology and circadian rhythms
The earliest link between psychopharmacology and circa-
dian rhythms came from the observation that lithium
slows down circadian periodicity in plants.
59These effects
of lithium are consistent across species,including humans,
60
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Table I. Chronobiological therapies of major depression. Therapies in italics are for one or two studies only. TSD, total sleep deprivation; PSD, par-
tial sleep deprivation; rTMS, repetitive transcranial magnetic stimulation; SSRI, selective serotonin reuptake inhibitor; SAD, seasonal affec-
tive disorder; MD, major depression.
Sleep manipulations Zeitgebers
TSD Light therapy (SAD)
PSD (second half of the night) Light therapy (nonseasonal MD)
Phase advance of the sleep-wake cycle Light therapy as adjuvant to SSRIs (nonseasonal MD)
TSD followed by phase advance Dark or rest therapy (rapid-cyclers)
Repeated TSD or PSD Dark therapy (mania)
Repeated TSD or PSD with antidepressants
Single or repeated TSD or PSD plus:
• Light therapy
• Light therapy and phase advance 
• rTMS
Single or repeated TSD or PSD plus 
• Lithium
• SSRIs 
• PindololChronobiology and mood disorders - Wirz-Justice Dialogues in Clinical Neuroscience - Vol 5 . No.4 . 2003
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and are measurable even at the level of individual SCN
neurones.
61 However,attempts to generalize across vari-
ous classes of antidepressant drugs have not been suc-
cessful
7: even though the monoamine oxidase inhibitor
(MAOI) clorgyline lengthened circadian period,
62 the
MAOI moclobemide shortened it,
63 and selective sero-
tonin reuptake inhibitors (SSRIs) had no effect.
63When
considering the model (Figure 1A),it is clear that drugs
could act not only on circadian period but may also change
phase position or phase relationships with the sleep-wake
cycle,to enhance circadian amplitude or sensitivity to zeit-
gebers.Evidence that imipramine and lithium modify the
phase angle between the circadian temperature rhythm
and the rest-activity cycle is interesting,
64 as is the concept
that stabilization of circadian rhythms may be a key action
of clinically effective mood-stabilizing drugs.
65 In addition,
sensitivity to light could be affected, as is the case with
chronic clorgyline and lithium treatments.
66
Nonpharmacological therapies
Sleep deprivation
Well documented is the rapid, usually short-lasting
improvement following total sleep deprivation and the
rapid return of depressive symptoms after subsequent
recovery sleep,indicating that the depressive process is
strongly sleep dependent.
8Additionally,sleep deprivation
needs to coincide with an early morning circadian phase
for optimal antidepressant response.Partial sleep depri-
vation in the second half of the night or phase-advance of
the sleep-wake cycle are equally efficacious (see Table I
for a list of therapeutic modalities). The spontaneous
switch out of depression (and into hypomania and mania)
often occurs after a “natural”sleep deprivation.
This remarkable and immediate antidepressant modal-
ity has been recognized for 30 years,but is little used in
everyday clinical practice. Perhaps it is the paradox of
taking sleep away from the depressive insomniac that has
a negative connotation for both patient and psychiatrist
(“wake therapy” would be a more positive alternative
name). Perhaps it is also the short-term nature of the
response that has hindered its use,though the magnitude
of the clinical changes brought about by sleep depriva-
tion still remain highly intriguing and may provide clues
for understanding the pathophysiology of depression.
Sleep deprivation is the paradigm par excellence for
depression research:rapid,nonpharmacological,and short
lasting.It may be the nonpharmacological nature of sleep
deprivation (it cannot be patented) that has contributed
to its status as an “orphan drug.”
67 It is surprising that no
pharmaceutical company has focused on this model to
search for that much-needed rapid-acting antidepressant.
8
This lack may be remedied in the future; new research
reveals that,whereas sleep induces very few genes,wake-
fulness increases expression of several groups of genes,
68
and here comparisons with the effects of antidepressant
drug treatment may narrow down the candidates.
Some committed proponents of sleep deprivation have
recognized its clinical usefulness to initiate rapid
improvement,particularly in the most severely depressed
patients in whom time is of the essence.Sleep depriva-
tion is effective in all diagnostic subgroups of depression.
The problem is the relapse after recovery sleep,and new
strategies have sought treatments to prevent this.
Response appears to be well maintained by treatment
with lithium,antidepressants (in particular SSRIs),or the
5-HT1A receptor antagonist pindolol, as well as non-
pharmacological adjuvants such as repetitive transcranial
magnetic stimulation (rTMS),
69 light therapy, or phase
advance of the sleep-wake cycle,or various combinations
thereof (see,for example,reference 36 and 70,reviewed
in reference 8;Table I).
Light therapy
Light therapy can be considered to be the most success-
ful clinical application of circadian rhythm concepts in
psychiatry to date. Light is the treatment of choice for
SAD.
71 The quality of recent SAD studies has been
exemplary,and the response rate is well above placebo
(in fact,superior to analogous trials with antidepressant
drugs).
72The success of this nonpharmacological treat-
ment has been astonishing,but it has taken rather long
for light therapy to be accepted by establishment psy-
chiatry,
72 and trials of other indications are still in the
research phase.Its very success in SAD has limited use
in other forms of depression (characterized as “it’s a
chronobiological treatment for a chronobiological sub-
set of depressive patients”).However,light acts on the
same neurotransmitters, in particular serotonin, as the
major antidepressant drugs.
71This has been shown with
tryptophan deletion tests,where relapse after successful
light therapy is induced,as well as the successful treat-
ment of SAD patients by SSRIs.
71 More direct evidence
of the immediate effects of light on serotonin turnover inthe brain has come from an in vivo study in healthy sub-
jects: not only is serotonin turnover high in spring and
summer and low in autumn and winter (the pattern fol-
lowing the hours of available sunshine), but serotonin
turnover increases immediately after light exposure.
73
Assuming that mood state is at least partially linked to
serotonin turnover, the conclusions are obvious: more
light,better mood.
The serotonin connection suggests that a broader use of
light therapy is indicated.A rapid response within a week
in SAD does not mean that other major depressive disor-
ders will improve so fast:trials of light therapy over at least
4 to 6 weeks,as would be standard for a drug treatment
trial,are required.There is already good evidence for effi-
cacy in bulimia, preliminary evidence for usefulness in
prepartum and postpartum depression (clinical indications
where new nondrug therapies are sorely needed),
74 and
promising findings in major depression,particularly as an
adjuvant (Table I).
74 Light is being recognized not only as
a major zeitgeber necessary for our daily well-being (with
applications in the work place and in architecture), but
also as a “drug”that can be prescribed in dose,timing,and
duration for specific diagnoses.
71
An important step forward for the clinician has been that
all available randomized studies of light therapy for both
SAD and nonseasonal depression are being analyzed for
efficacy, and will soon be published in the Cochrane
Library (www.cochrane.de).
“Dark” therapy
Single case studies of rapidly cycling bipolars have shown
that extending darkness (or rest,or sleep) immediately
stops the recurring pattern,which is a rather astonishing
result in these therapy-resistant patients.
38,39 Further sup-
port comes from recent findings that extended darkness
(not rest and not sleep) in manic bipolar patients can
control their symptoms within days (B.Barbini,personal
communication).
The pineal hormone melatonin is designated the “hormone
of darkness.”Physiologically,it is important for timing the
cascade of events initiating sleep in humans.
20The noctur-
nal onset of melatonin secretion opens the gateway for
sleep propensity,involving peripheral thermoregulatory
mechanisms.
75The “warm feet effect”underlies its soporific
action and use in a variety of sleep disorders.
20 The few
studies administering melatonin to depressed patients have
indeed found improvements in sleep,but not in mood.
76,77
Emerging therapies
New drugs,such as agomelatine (a melatonin agonist and
5-HT2c antagonist), with a core action on circadian
rhythms,are currently in development for the treatment
of mood disorders.
A large multicenter study investigating agomelatine in
major depression has yielded an excellent antidepressant
response,
78 which has been linked to the action of the
compound on the melatonergic and serotonergic systems.
Moreover,the 5-HT2c receptor subtype is considered to
be relevant to the therapeutic properties of SSRIs,and—
to link this to chronobiology—5-HT2c receptor agonists,
which mimic the effects of light in rat CNS.
79
Sleep shifts and zeitgebers as therapy 
The above concepts point toward a multimodal approach
to using chronobiological therapies in major depression.
“Wake therapy”(increasing the level of process S) induces
rapid clinical improvement in all diagnostic subgroups;
phase advance (changing the timing of sleep) maintains
the response,as does light,drugs acting on the serotoner-
gic system,or rTMS (which acts on the SCN
80).Increasing
zeitgeber strength improves the consistency of entrain-
ment and circadian amplitude:this may be one mechanism
underlying the therapeutic efficacy of bright light and the
melatonin agonist. There is evidence that depressed
patients,including those with SAD,have greater day-to-
day and within-day mood variability than controls.
81,82 In
SAD patients,it has been shown that increasing zeitgeber
strength with light therapy reduced or eliminated both
group differences in mean level and variability of mood.
82
Other zeitgebers (social cues,activity,and food) are impor-
tant for improving behavioral feedback from peripheral
clocks to overall entrainment stability.This is extremely
important in bipolar patients.
37The combination needed
by the clinician for the sought-after rapid and long-lasting
antidepressant,might well be an eclectic mix of these non-
pharmacological modalities with antidepressant drugs.
Conclusion
We live in a 24-h society that is no longer strongly syn-
chronized to the change in daylength or temperature
across the seasons.A permanent “summer day” is the
result of artificial lighting,yet it is of insufficient intensity
for stable entrainment.Too little is known of the seque-
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ble circadian system,and how light could trigger or alle-
viate a depressive phase. Could part of the increase in
prevalence of depression in modern society be related to
such factors? Genetic predisposition,hormonal fluctua-
tions,environmental stress,and altered light-dark cycles
could all induce rhythm disturbances.Conversely,altered
sleep patterns,hyperarousal,eating behavior,and mood
state could feed back onto the circadian system via hor-
mones and effects on peripheral oscillators.These new
insights provide us with useful strategies and a variety of
methods to improve robustness of the circadian pace-
maker and better synchronize its timing with respect to
the day-night cycle.It is interesting to reconsider those
empirically developed 19th century psychiatric treat-
ments,which consisted of establishing regularity in social
schedules and meal times,and manipulating sleep (albeit
with “cures”) and temperature (with cold baths),in terms
of modern chronobiology and the importance of cor-
rectly timed zeitgebers. ❏
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Cronobiología y trastornos afectivos
Las observaciones clínicas de la variación diurna del ánimo y el despertar precoz en la depresión se han incor-
porado a sistemas diagnósticos establecidos, como es el caso de la modificación estacional que define la depre-
sión invernal (trastorno afectivo estacional, TAE). Muchos ritmos circadianos medidos en pacientes depresi-
vos son anormales: por ocurrir antes del tiempo que corresponde, tener una amplitud disminuida o una mayor
variabilidad. Para precisar si estas alteraciones tienen un significado etiológico en el rol que cumplen los rit-
mos circadianos en los trastornos afectivos o si son una consecuencia de conductas alteradas se requiere de
un análisis minucioso con protocolos muy estrictos (por ejemplo, rutina constante o desincronía forzada).
Estos protocolos cuantifican las contribuciones del marcapaso circadiano y del proceso de sueño homeostá-
tico que influyen en el ánimo, la energía, el apetito y el sueño. Estudios futuros aclararán algunas mutacio-
nes alélicas de genes relacionados con el “reloj circadiano” o el “sueño” en la depresión. Respecto al trata-
miento, los antidepresivos y los estabilizadores del ánimo no tienen efectos consistentes en la ritmicidad
circadiana. La estrategia antidepresiva más rápida conocida hasta la fecha es de tipo no farmacológico: la pri-
vación total o parcial de sueño durante la segunda mitad de la noche. La desventaja de la privación de sueño
es que la mayoría de los pacientes recaen después de recuperar el sueño; esto puede prevenirse mediante la
coadministración de litio, pindolol, inhibidores de la recaptación de serotonina (5-HT), luz brillante, o a tra-
vés de un procedimiento posterior de avance de fase. El avance de fase del ciclo sueño vigilia en forma exclu-
siva tiene también rápidos efectos en el ánimo depresivo, lo que dura mayor tiempo que la privación de
sueño. La luz es el tratamiento de elección para el TAE y puede resultar útil en la depresión no estacional al
administrarla sola o en combinación con medicamentos. Los conceptos cronobiológicos enfatizan el impor-
tante papel de los “zeitgebers” para estabilizar la fase, siendo la luz el más importante, pero también se
deben considerar los períodos de oscuridad (y reposo), la regularidad de los horarios sociales y de las comi-
das y el empleo de melatonina o de sus análogos. Los avances en la cronobiología continúan para contribuir
a nuevos tratamientos para los trastornos afectivos.
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Chronobiologie et troubles de l’humeur
Les observations cliniques de variations diurnes de l’humeur et de réveil matinal précoce dans la dépression
ont été intégrées dans des systèmes diagnostiques établis tel le facteur saisonnier qui définit la dépression
hivernale (trouble affectif saisonnier, TAS). Beaucoup de rythmes circadiens mesurés chez les patients dépres-
sifs sont anormaux : plus précoces, diminués en amplitude ou de plus grande variabilité. Seuls des protoco-
les rigoureux (par exemple, routine constante ou désynchronisation forcée) sont à même de déterminer si
ces perturbations ont une signification étiologique quant au rôle des rythmes circadiens dans les troubles de
l’humeur ou si elles sont la conséquence d’une modification comportementale. Ces protocoles quantifient
les participations respectives de l’oscillateur circadien et d’un processus homéostatique lié au sommeil ayant
des répercussions sur l’humeur, l’énergie, l’appétit et le sommeil. Les études à venir mettront en évidence,
si tant est qu’elles existent, les mutations alléliques des gènes qui interviennent dans les phénomènes « d’hor-
loge » ou de « sommeil » au cours de la dépression. En ce qui concerne le traitement, les antidépresseurs et
les régulateurs de l’humeur n’ont pas d’effet constant sur le rythme circadien. L’effet antidépresseur le plus
rapide connu à ce jour n’est pas pharmacologique : c’est la privation totale ou partielle de sommeil dans la
seconde moitié de la nuit. L’inconvénient de la privation de sommeil, constitué par la rechute de la plupart
des patients après le sommeil de récupération, peut être prévenu par l’administration concomitante de li-
thium, de pindolol, d’inhibiteurs de la recapture de la sérotonine (5-HT), de lumière vive ou par une procé-
dure d’avance de phase. L’avance de phase dans les cycles veille-sommeil exerce par elle-même également
des effets rapides sur l’humeur dépressive qui se maintiennent plus longtemps que ceux de la privation de
sommeil. La photothérapie est le traitement de choix du TAS et pourra s’avérer utile dans la dépression non
saisonnière, seule ou en association à un traitement médicamenteux. Les concepts chronobiologiques sou-
lignent le rôle important des synchroniseurs dans la stabilisation de phase, la lumière étant le plus important.
Cependant, les périodes d’obscurité (et de repos), la régularité des repas et des rythmes sociaux et l’utilisa-
tion de la mélatonine ou de ses analogues doivent être également considérées. Les avancées en chronobio-
logie continuent à contribuer au développement de médicaments nouveaux dans les troubles affectifs.